Literature DB >> 18667105

High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice.

J von Oettingen1, M Nath-Chowdhury, B J Ward, A C Rodloff, M J Arrowood, M Ndao.   

Abstract

To date, large-scale production of Cryptosporidium parvum oocysts has only been achieved by amplification in neonatal calves and sheep. Many laboratories currently depend on supplies from external sources and store oocysts for prolonged periods which results in progressive loss of viability. Six to 8-week-old interferon gamma receptor knockout (IFN gamma R-KO) mice on a C57BL/6 background were inoculated by gavage (2000 oocysts/animal). Fecal pellets were collected daily from 7 days post-infection (p.i.) up to 2 weeks p.i. Intestinal oocyst yield was assessed at days 11, 12 and 14 p.i. by homogenization of intestinal tissues. Ether extraction and one or more NaCl flotations were used to purify oocysts. Total recoveries averaged 2.6 x 10(6) oocysts/mouse from fecal material and 3.8 x 10(7) oocysts/mouse from intestinal tissues. Overall, 2.3 x 10(9) purified oocysts were obtained from 60 mice. Recovered oocysts were capable of sporulation and were shown to be infectious both in vitro and in vivo. Oocyst amplification was achieved in only 11-14 days with minimal expense. The simplicity of this method presents a practical alternative for the routine passage, maintenance and storage of C. parvum in biomedical laboratories.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667105     DOI: 10.1017/S0031182008004757

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  11 in total

1.  Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice.

Authors:  Rihua Xu; Honglin Jia; Mohamad Alaa Terkawi; Xuenan Xuan; Heping Zhang
Journal:  Curr Microbiol       Date:  2011-02-20       Impact factor: 2.188

2.  A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.

Authors:  Momar Ndao; Milli Nath-Chowdhury; Mohammed Sajid; Victoria Marcus; Susan T Mashiyama; Judy Sakanari; Eric Chow; Zachary Mackey; Kirkwood M Land; Matthew P Jacobson; Chakrapani Kalyanaraman; James H McKerrow; Michael J Arrowood; Conor R Caffrey
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

Review 3.  Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases.

Authors:  Anjan Debnath; Momar Ndao; Sharon L Reed
Journal:  Gut Microbes       Date:  2012-11-08

Review 4.  Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.

Authors:  Maxime W Lemieux; Karine Sonzogni-Desautels; Momar Ndao
Journal:  Pathogens       Date:  2017-12-24

5.  Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro.

Authors:  Georgia Wilke; Soumya Ravindran; Lisa Funkhouser-Jones; Jennifer Barks; Qiuling Wang; Kelli L VanDussen; Thaddeus S Stappenbeck; Theresa B Kuhlenschmidt; Mark S Kuhlenschmidt; L David Sibley
Journal:  mSphere       Date:  2018-05-30       Impact factor: 4.389

6.  Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.

Authors:  Xuejin Zhang; Chi Yong Kim; Tori Worthen; William H Witola
Journal:  Int J Parasitol       Date:  2018-03-09       Impact factor: 3.981

Review 7.  Past and future trends of Cryptosporidium in vitro research.

Authors:  Alexander J Bones; Lyne Jossé; Charlotte More; Christopher N Miller; Martin Michaelis; Anastasios D Tsaousis
Journal:  Exp Parasitol       Date:  2018-12-03       Impact factor: 2.011

8.  A Stem-Cell-Derived Platform Enables Complete Cryptosporidium Development In Vitro and Genetic Tractability.

Authors:  Georgia Wilke; Lisa J Funkhouser-Jones; Yi Wang; Soumya Ravindran; Qiuling Wang; Wandy L Beatty; Megan T Baldridge; Kelli L VanDussen; Bang Shen; Mark S Kuhlenschmidt; Theresa B Kuhlenschmidt; William H Witola; Thaddeus S Stappenbeck; L David Sibley
Journal:  Cell Host Microbe       Date:  2019-06-20       Impact factor: 21.023

9.  Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice.

Authors:  Karine Sonzogni-Desautels; Axel E Renteria; Fabio V Camargo; Thomas Z Di Lenardo; Alexandre Mikhail; Michael J Arrowood; Anny Fortin; Momar Ndao
Journal:  Front Microbiol       Date:  2015-09-23       Impact factor: 5.640

Review 10.  Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.

Authors:  Yukiko Miyamoto; Lars Eckmann
Journal:  Front Microbiol       Date:  2015-11-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.